Caligan Partners LP
Annual return '25
+14.4%
SPY '25
+17.7%
Alpha
-3.3ptsvs SPY
Invested
$1.5B
Holdings
26
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$LQDA
LIQUIDIA CORPORATION
Q4 2024: New position (8.12M shares)
20.4%
02
$RVMD
REVOLUTION MEDICINES INC
Q3 2025: Increased +67.1% (636.8k → 1.06M shares)
12.2%
03
$ABVX
ABIVAX SA
Q3 2025: Sold 13.3% (1.67M → 1.45M shares)
10.8%
04
$PCVX
VAXCYTE INC
Held since at least Q1 2024
8.0%
05
$XENE
XENON PHARMACEUTICALS INC
Q3 2025: New position (444.6k shares)
5.4%
06
$MLYS
MINERALYS THERAPEUTICS INC
Q3 2025: Increased +37.4% (2.02M → 2.77M shares)
5.0%
07
$EXEL
EXELIXIS INC
Q4 2024: New position (1.53M shares)
4.4%
08
$CGON
CG ONCOLOGY INC
Held since at least Q1 2024
4.1%
09
$TNGX
TANGO THERAPEUTICS INC
Held since at least Q1 2024
3.4%
10
$TYRA
TYRA BIOSCIENCES INC
Q3 2025: Increased +266.9% (190.0k → 696.8k shares)
3.3%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:22 UTC.